Document Type : Original Article(s)
Authors
- Farideh Jowkar 1
- Fateme Sari Aslani 2
- Leila Samipour 3
- Fateme Mohebpour 4
- Maryam Hadibarhaghtalab 4
- Negin Fazelzadeh Haghighi 4
- Kaveh Taghipour 4
1 Department of Dermatology, Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Department of Pathology, Shiraz University of Medical Science, Shiraz, Iran
3 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
4 Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract
Background: Basal cell carcinoma (BCC) is the most prevalent type of skin cancer in Iran. The determination of subtype of BCC plays an essential role in the diagnosis, recurrence rate, and outcome of patients. The present study was conducted to investigate the relationship between histopathologic subtypes and demographic data, history of radiation exposure, and past medical history in the Iranian population.
Method: This retrospective cross-sectional study evaluated the patients with BCC referred to Faghihi Hospital, Shiraz, Iran from 2012 to 2017. We examined all the patients with definite histologically diagnosed scalp BCC. The prevalence of different subtypes and its association with other variables were compared between the patients with and without chronic radio-dermatitis. A P-value of less than 0.05 was considered to be significant.
Results: A total number of 161 patients with a cumulative number of 439 BCC lesions participated in the study. The mean age of the patients was 64.2 (± 12.38) years old. Among the patients, 113 (70.2%) were men and 48 (29.8%) were women. The total prevalence of macro-nodular, micro-nodular, and mixed aggressive was 70.2%, 49.1%, and 41.6%, respectively. Multivariate logistic regression analysis showed that excessive sun exposure increased the chance of developing micronodular and mixed aggressive lesions by 3.21 (P = 0.006) and 4.88 (P < 0.001) times, respectively.
Conclusion: BCC was more aggressive in chronic radio-dermatitis patients than that in non-radio-dermatitis patients. Moreover, it was significantly different regarding age, gender, appearance, and job distribution compared with non-radio-dermatitis patients. Thus, we could suggest that BCC in chronic radio-dermatitis should be regarded as a high-risk disease, unless proven otherwise.
Keywords
How to cite this article:
Jowkar F, Sari Aslani F, Samipour L, Mohebpour F, Hadibarhaghtalab M, Fazelzadeh Haghighi N, et al. Determination of the frequency of scalp basal cell carcinoma subtypes based on histopathology and other related variables and its comparison between patients with and without chronic radio-dermatitis. Middle East J Cancer. 2022;13(1):74-80. doi: 10.30476/mejc.2021.84775. 1232.
2.Vakili M, Pirdehghan A, Adimi M, Sadeghian M, Akhondi M. Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005-2009. J Res Health Sci. 2014;14(3):210-3.
3.Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev. 2015;16(4):1409-13. doi: 10.7314/APJCP.2015. 16.4.1409
4.Zargari O. Radiation-induced basal cell carcinoma. Dermatol Pract Concept. 2015;5(2):109-12. doi: 10.5826/dpc.0502a22.
5.Razi S, Enayatrad M, Mohammadian-Hafshejani A, Salehiniya H, Fathali-Loy-Dizaji M, Soltani S. The epidemiology of skin cancer and its trend in Iran. Int J Prev Med. 2015;6:64. doi: 10.4103/2008-7802.161074.
6.Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069-80. doi: 10.1111/j.1365-2133.2012.10830.x.
7.Feller L, Khammissa R, Kramer B, Altini M, Lemmer J. Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face. Head Face Med. 2016;12(1):11. doi: 10.1186/s13005-016-0106-0.
8.Kim Y, He YY. Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation. Genes Dis. 2014;1(2):188-98. doi: 10.1016/j.gendis.2014.08.005.
9.Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008;8(10):743. doi: 10. 1038/nrc2503.
10.Hassanpour SE, Kalantar-Hormozi A, Motamed S, Moosavizadeh SM, Shahverdiani R. Basal cell carcinoma of scalp in patients with history of childhood therapeutic radiation: a retrospective study and comparison to nonirradiated patients. Ann Plast Surg 2006;57(5):509-12. doi: 10.1097/01.sap.000022 9002.09605.5d.
11.Raasch B, Buettner P, Garbe C. Basal cell carcinoma: histological classification and body-site distribution. Br J Dermatol. 2006;155(2):401-7. doi: 10.1111/j. 1365-2133.2006.07234.x.
12.Weedon D. Tumors of the epidermis. Skin Pathology. 2002:753-802.
13.Razi S, Rafiemanesh H, Ghoncheh M, Khani Y, Salehiniya H. Changing trends of types of skin cancer in Iran. Asian Pac J Cancer Prev. 2015;16(12):4955-8. doi: 10.7314/APJCP.2015.16.12.4955.
14.Boaventura P, Oliveira R, Pereira D, Soares P, Teixeira-Gomes J. Head and neck basal cell carcinoma prevalence in individuals submitted to childhood X-ray epilation for tinea capitis treatment. Eur J Dermatol. 2012;22(2):225-30. doi:10.1684/ejd.2012.1670.
15.Al-Qarqaz F, Marji M, Bodoor K, Almomani R, Al Gargaz W, Alshiyab D, et al. Clinical and demographic features of basal cell carcinoma in north Jordan. J Skin Cancer. 2018;2018:5. doi: 10.1155/2018/2624054.
16.Lesiak A, Slowik-Rylska M, Rogowski-Tylman M, Sysa-Jedrzejowska A, Norval M, Narbutt J. Risk factors in Central Poland for the development of superficial and nodular basal cell carcinomas. Arch Med Sci.2010;6(2):270-5. doi: 10.5114/aoms.2010. 13907.
17.Deja M, Teresiak E, Buczynska-Górna M, Karas A, Jenerowicz D. Analysis of the appearance of different histological types of basal cell carcinoma, localization of the lesions, the age and sex of patients. Postepy Dermatol Alergol. 2004;21(5):231.
18.Gursan N. Bazal hucreli karsinomlarin klinik ve histopatolojik degerlendirilmesi. Turk J Dermatopathol. 2000;9:23-8.
19.Ciążyńska M, Narbutt J, Woźniacka A, Lesiak A. Trends in basal cell carcinoma incidence rates: a 16-year retrospective study of a population in central Poland. Postepy Dermatol Alergol. 2018;35(1):47-52. doi: 10.5114/ada.2018.73164.
20.Arits A, Schlangen M, Nelemans P, Kelleners-Smeets N. Trends in the incidence of basal cell carcinoma by histopathological subtype. J Eur Acad Dermatol Venereol. 2011;25(5):565-9. doi:10.1111/j.1468-3083.2010.03839.x.
21.Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147(1):41-7. doi: 10.1046/j.1365-2133.2002. 04804.x.
23.Bauer A, Diepgen T, Schmitt J. Is occupational solar ultraviolet irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta-analysis of the epidemiological literature. Br J Dermatol. 2011; 165(3):612-25. doi: 10.1111/j.1365-2133.2011.10425.x.
24.Pelucchi C, Di Landro A, Naldi L, La Vecchia C. Risk factors for histological types and anatomic sites of cutaneous basal-cell carcinoma: an italian case-control study. J Invest Dermatol. 2007;127(4):935-44. doi: 10.1038/sj. jid.5700598.
25.Meibodi NT, Maleki M, Javidi Z, Nahidi Y. Clinicopathological evaluation of radiation induced basal cell carcinoma. Indian J Dermatol. 2008;53(3):137. doi: 10.4103/0019-5154.43222.
26.Oshinsky S, Baum S, Huszar M, Debby A, Barzilai A. Basal cell carcinoma induced by therapeutic radiation for tinea capitis-clinicopathological study. Histopathology. 2018;73(1):59-67. doi: 10.1111/his.13497.
)